Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
  1. 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
  2. 4 Grant or award Director acquired 17,857 shares (grant or award)
  3. 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
  4. 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
  5. 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
  6. 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
  7. 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
  8. 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
  9. 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
  10. 4 Grant or award Director acquired 17,857 shares (grant or award)
  11. 4 Open-market buy 10% owner bought 17,857 shares at $56.00 ($999,992)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale Director sold 1,156 shares at an average $37.69 ($43,573)
  15. 4 Open-market sale Director sold 968 shares at an average $41.97 ($40,632)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 5 of 18 · 354 filings